{'fraction_non_alphanumeric': 0.029038112522686024, 'fraction_numerical': 0.0, 'mean_word_length': 5.4941176470588236, 'pattern_counts': {'":': 0, '<': 0, '<?xml version=': 0, '>': 0, 'https://': 0, 'lorem ipsum': 0, 'www.': 0, 'xml': 0}, 'pii_count': 0, 'substrings_counts': 0, 'word_list_counts': {'cursed_substrings.json': 0, 'profanity_word_list.json': 0, 'sexual_word_list.json': 0, 'zh_pornsignals.json': 0}}
Reporting trends of adverse effects from proton pump inhibitors to the food and drug administration

Recent publications have described new potential proton pump inhibitor (PPI)‐associated adverse effects (AEs). There is public interest and potential for lawsuits for these and other PPI‐related AEs. Post‐marketing surveillance reports of AEs can be found on the Food and Drug Administration Adverse Event Reporting System (FAERS) database. The aim of this study is to analyse reports of all PPI‐associated‐AEs to FAERS, focusing on reporter sources.